Addrenex being bought by Sciele
Get the latest news alerts: Follow LTW at Twitter
Local Tech Wire
RESEARCH TRIANGLE PARK, N.C. — Atlanta-based Sciele Pharma Inc., said Monday that it will acquire Durham-based Addrenex Pharmaceuticals Inc., in a deal valued at $29 million.
Sciele is part of Shionogi & Co. Ltd., which has its headquarters in Osaka, Japan.
Addrenex specializes in developing drugs that regulate the adrenergic system. Sciele previously licensed Addrenex's Clonicel for attention deficit hyperactivity disorder (ADHD), and Jenloga XR (once-daily clonidine) for hypertension. They filed last month seeking FDA approval for Clonicel.
In addition, Sciele licensed rights to ADX-415 for the treatment of vasomotor systems and hypertension.
Patrick Fourteau, Sciele president and chief executive officer, said, "Addrenex has an exciting development platform and several compounds that have the potential to further expand and diversify our product portfolio."
Moise A. Khayrallah, Addrenex CEO and co-founder, said, "Sciele Pharma has been a valuable partner and catalyst for the success of Addrenex. The partnership has enabled our team to expand the development pipeline and now gives Sciele access to a large portfolio of products that offer tremendous promise for patients and their families."
Addrenex got started with help from the state's North Carolina Biotechnology Center. The company received $160,000 in early stage support via two loans 2006 – a $25,000 Business Development Loan (BDL) and a $135,000 Small Business Research loan (SRL).
In the wake of the sale, the company has repaid the Biotechnology Center a total of $203,511.39 in principal and interest, the center reported Monday.
The Biotechnology Center also took warrants in the company as part of the loan agreement. With the sale to Sciele, those warrants generated a cash payout of $289,323.70.
Copyright 2010 Local Tech Wire. All rights reserved.Featured
Hot Off The Wire
- Hot Off the Wire – Google slashes Nexus One termination fee; MySpace Music tunes up audio ads; Barry Diller’s IAC beats Street
- Hot Off the Wire – Man convicted in first economic espionage case; iPhone market share grows; Electronic Arts shares falter after revenue forecast; Phone company wants to charge Google
- FairPoint looks to cut debt by two thirds with bankruptcy plan
E-mail Preferences
The Skinny
- Gears of War 3 coming? EA discloses Epic game for 2011
- Nagoya University bridges East, West with Nu Tech event
- E-mail services provider iContact investigating a hack attack
- Cyberespionage? Cyberslueths disclose Lenovo’s 2010 ‘roadmap’
- Tech recovery is at hand, analysts tells N.C. IT execs
- Believe it - Triangle region lands record $1.9B in business projects
- Epic Games’ heroes take their guns to a new world – ‘Lost Planet 2’
- IPO rewards: Motricity CEO gets a $75,000 raise in new contract
- IT recession over? Spending will rebound, analysis firm says
- Google vs. the Dragon – War over words could ignite into flames

